City

Chicago (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

University of Chicago (1)

Collaborator

National Cancer Institute (NCI) (1)

Intervention

laboratory biomarker analysis (1)

pembrolizumab (1)

pharmacogenomic study (1)

Study Documents

Intervention Type

biological (1)

other (1)

Funder Type

Other (1)

Study Type

Interventional (1)

biphasic mesothelioma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Biphasic Mesothelioma, Epithelioid Mesothelioma, Peritoneal Malignant Mesothelioma Trial in Chicago (Pembrolizumab, Laboratory

Active, not recruiting

Biphasic Mesothelioma
+9 more

Pembrolizumab
+2 more

Chicago, Illinois

University of Chicago

Apr 18, 2022